Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
ORLANDO, Fla., Feb. 21, 2014 /PRNewswire/ -- To satisfy the need among radiation and medical oncology practices for greater sophistication in information management systems, Elekta (booth #3503) will demonstrate a number of new features in its MOSAIQ® Oncology Information System (OIS) at the Healthcare Information and Management Systems Society's 2014 annual conference and exhibition (HIMSS14), February 23-27, in Orlando, Florida. Notably, Elekta will highlight new functionality optimized for today's rapidly consolidating oncology care delivery systems.
For MOSAIQ users in the United States, Elekta will demonstrate a wealth of new functionality being deployed today that allows practices to consolidate their patient records and workflows into a single system, including advanced scheduling, improved connectivity to treatment delivery devices and reporting tools to ensure treatment data is applied to future care decisions. This will also include ePrescribing, an integrated Patient Portal, and IQ Scripts.
"This is an important meeting for those of us who are anticipating the IT and health information needs as the US healthcare system continues to consolidate," says Richard Stark, Senior Vice President of Elekta Software. "MOSAIQ is the tool of choice for healthcare delivery systems that require a scalable solution that easily integrates with enterprise systems, yet incorporates best-in-class functionality, advanced workflow management tools and redundant safety features designed for cancer treatment centers."
MOSAIQ is a comprehensive OIS that centralizes traditional radiation oncology, particle therapy and medical oncology patient data into a single user interface, accessible by multidisciplinary teams across multiple locations. MOSAIQ provides oncology staff access to the underlying clinical and administrative data, improving both clinical care and operational efficiency.
MOSAIQ earned Best in KLAS recognition in 2011 and 2012, and Category Leader KLAS in 2010 and 2013*.
Visitors to Elekta booth #3503 will learn how MOSAIQ integrates with a varied array of hospital systems, treatment devices and imaging systems, increasing accessibility to critical data anytime by remote users on various platforms. MOSAIQ captures the entire patient chart in a common database that users can customize, allowing radiation oncologists and medical oncologists to coordinate care for complex cases.
*2010-2013 Best in KLAS: Software and Services. January, 2014. KLAS enterprises, LLC. All rights reserved. www.KLASresearch.com.
For further information, please contact:
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, email: firstname.lastname@example.org
Time zone: CET: Central European Time
Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: email@example.com
Time zone: ET: Eastern Time
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.
©2012 PR Newswire. All Rights Reserved.